{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:00:05Z","timestamp":1793350805681,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T00:00:00Z","timestamp":1729728000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI22C2101"],"award-info":[{"award-number":["HI22C2101"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["R21AI176069"],"award-info":[{"award-number":["R21AI176069"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK130425"],"award-info":[{"award-number":["R01DK130425"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["75N93019C00046"],"award-info":[{"award-number":["75N93019C00046"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["75N93021C00014"],"award-info":[{"award-number":["75N93021C00014"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI160706"],"award-info":[{"award-number":["R01AI160706"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["G20AI174733"],"award-info":[{"award-number":["G20AI174733"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21AI176069"],"award-info":[{"award-number":["R21AI176069"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017065","name":"Rogel Cancer Center, University of Michigan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ymthe.2024.10.016","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T03:03:05Z","timestamp":1730257385000},"page":"4448-4466","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Enhanced mucosal SARS-CoV-2 immunity after heterologous intramuscular mRNA prime\/intranasal protein boost vaccination with a combination adjuvant"],"prefix":"10.1016","volume":"32","author":[{"given":"Gabriel","family":"Laghlali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Wiest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilara","family":"Karadag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prajakta","family":"Warang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica J.","family":"O\u2019Konek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren A.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok-Chan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Farazuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna W.","family":"Janczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolfo","family":"Garc\u00eda-Sastre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"James R.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela T.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schotsaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2024.10.016_bib1","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41586-021-04387-1","article-title":"Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization","volume":"602","author":"Cele","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2024.10.016_bib2","doi-asserted-by":"crossref","first-page":"5851","DOI":"10.1038\/s41467-023-41537-7","article-title":"mRNA-1273 bivalent (original and Omicron) COVID-19 vaccine effectiveness against COVID-19 outcomes in the United States","volume":"14","author":"Tseng","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.10.016_bib3","doi-asserted-by":"crossref","DOI":"10.1172\/JCI167955","article-title":"Durability of immune responses to mRNA booster vaccination against COVID-19","volume":"133","author":"Arunachalam","year":"2023","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2024.10.016_bib4","doi-asserted-by":"crossref","DOI":"10.1126\/science.abm0829","article-title":"mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern","volume":"374","author":"Goel","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2024.10.016_bib5","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/cid\/ciac785","article-title":"Effectiveness of Messenger RNA-1273 Vaccine Booster Against Coronavirus Disease 2019 in Immunocompetent Adults","volume":"76","author":"Florea","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ymthe.2024.10.016_bib6","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/s41591-022-01699-1","article-title":"Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England","volume":"28","author":"Andrews","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2024.10.016_bib7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1056\/NEJMc2214293","article-title":"Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent Booster","volume":"388","author":"Davis-Gardner","year":"2023","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.10.016_bib8","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1016\/S1473-3099(23)00779-X","article-title":"Humoral immune responses to the monovalent XBB.1.5-adapted BNT162b2 mRNA booster in Sweden","volume":"24","author":"Marking","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ymthe.2024.10.016_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(23)00105-2","article-title":"Bivalent mRNA vaccine-elicited SARS-CoV-2 specific T\u00a0cells recognise the omicron XBB sublineage","volume":"4","author":"Traut","year":"2023","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.ymthe.2024.10.016_bib10","article-title":"BNT162b2 XBB1.5-adapted Vaccine and COVID-19 Hospital Admissions and Ambulatory Visits in US Adults","author":"Tartof","year":"2023","journal-title":"medRxiv"},{"key":"10.1016\/j.ymthe.2024.10.016_bib11","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41577-021-00583-2","article-title":"Mucosal vaccines \u2014 fortifying the frontiers","volume":"22","author":"Lavelle","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2024.10.016_bib12","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/infdis\/jiad353","article-title":"SARS-CoV-2 Hybrid Immunity: The Best of Both Worlds","volume":"228","author":"Lasrado","year":"2023","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ymthe.2024.10.016_bib13","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.165265","article-title":"An extended interval between vaccination and infection enhances hybrid immunity against SARS-CoV-2 variants","volume":"8","author":"Bates","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymthe.2024.10.016_bib14","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1021\/acs.molpharmaceut.0c00315","article-title":"Combined Intranasal Nanoemulsion and RIG-I Activating RNA Adjuvants Enhance Mucosal, Humoral, and Cellular Immunity to Influenza Virus","volume":"18","author":"Wong","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ymthe.2024.10.016_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.729189","article-title":"A Combination Adjuvant for the Induction of Potent Antiviral Immune Responses for a Recombinant SARS-CoV-2 Protein Vaccine","volume":"12","author":"Jangra","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2024.10.016_bib16","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41541-023-00691-1","article-title":"Multicomponent intranasal adjuvant for mucosal and durable systemic SARS-CoV-2 immunity in young and aged mice","volume":"8","author":"Jangra","year":"2023","journal-title":"NPJ Vaccin."},{"key":"10.1016\/j.ymthe.2024.10.016_bib17","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/embor.2013.102","article-title":"ATPase-driven oligomerization of RIG-I on RNA allows optimal activation of type-I interferon","volume":"14","author":"Patel","year":"2013","journal-title":"EMBO Rep."},{"key":"10.1016\/j.ymthe.2024.10.016_bib18","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.vaccine.2011.10.094","article-title":"Safety and immunogenicity of a novel nanoemulsion mucosal adjuvant W805EC combined with approved seasonal influenza antigens","volume":"30","author":"Stanberry","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2024.10.016_bib19","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.4049\/jimmunol.1301424","article-title":"Distinct pathways of humoral and cellular immunity induced with the mucosal administration of a nanoemulsion adjuvant","volume":"192","author":"Bielinska","year":"2014","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2024.10.016_bib20","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.vaccine.2012.12.033","article-title":"Nanoemulsion nasal adjuvant W\u2088\u20805EC induces dendritic cell engulfment of antigen-primed epithelial cells","volume":"31","author":"Myc","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2024.10.016_bib21","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/j.vaccine.2015.03.002","article-title":"Nanoemulsion-based mucosal adjuvant induces apoptosis in human epithelial cells","volume":"33","author":"Orzechowska","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2024.10.016_bib22","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.4049\/jimmunol.173.3.1978","article-title":"Role of IgA versus IgG in the Control of Influenza Viral Infection in the Murine Respiratory Tract1","volume":"173","author":"Renegar","year":"2004","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2024.10.016_bib23","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/COH.0b013e328335c2f6","article-title":"Th17 cytokines in mucosal immunity and inflammation","volume":"5","author":"Guglani","year":"2010","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.ymthe.2024.10.016_bib24","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41577-022-00746-9","article-title":"IL-17 and IL-17-producing cells in protection versus pathology","volume":"23","author":"Mills","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2024.10.016_bib25","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/mi.2016.28","article-title":"Vaccine-induced Th17 cells are established as resident memory cells in the lung and promote local IgA responses","volume":"10","author":"Christensen","year":"2017","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.ymthe.2024.10.016_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003875","article-title":"Intranasal vaccination promotes detrimental Th17-mediated immunity against influenza infection","volume":"10","author":"Maroof","year":"2014","journal-title":"Plos Pathog."},{"key":"10.1016\/j.ymthe.2024.10.016_bib27","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3390\/cells10051159","article-title":"Th17 Cells in Viral Infections-Friend or Foe?","volume":"10","author":"Paiva","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ymthe.2024.10.016_bib28","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2118312119","article-title":"Vaccine-induced systemic and mucosal T\u00a0cell immunity to SARS-CoV-2 viral variants","volume":"119","author":"Kingstad-Bakke","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2024.10.016_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abq7647","article-title":"CD8 T\u00a0cells contribute to vaccine protection against SARS-CoV-2 in macaques","volume":"7","author":"Liu","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.ymthe.2024.10.016_bib30","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nprot.2014.005","article-title":"Intravascular staining for discrimination of vascular and tissue leukocytes","volume":"9","author":"Anderson","year":"2014","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ymthe.2024.10.016_bib31","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1038\/s41467-022-30763-0","article-title":"Characterization of SARS-CoV-2 Spike mutations important for infection of mice and escape from human immune sera","volume":"13","author":"Rathnasinghe","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.10.016_bib32","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41586-022-04441-6","article-title":"SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters","volume":"603","author":"Halfmann","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2024.10.016_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/science.abo2523","article-title":"Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses","volume":"378","author":"Mao","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2024.10.016_bib34","doi-asserted-by":"crossref","first-page":"5065","DOI":"10.1038\/s41467-023-40592-4","article-title":"Omicron infection following vaccination enhances a broad spectrum of immune responses dependent on infection history","volume":"14","author":"Hornsby","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.10.016_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104893","article-title":"SARS-CoV-2 convalescence and hybrid immunity elicits mucosal immune responses","volume":"98","author":"Puhach","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ymthe.2024.10.016_bib36","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S1473-3099(22)00801-5","article-title":"Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression","volume":"23","author":"Bobrovitz","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ymthe.2024.10.016_bib37","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.1038\/s41467-023-40076-5","article-title":"Genetically diverse mouse models of SARS-CoV-2 infection reproduce clinical variation in type I interferon and cytokine responses in COVID-19","volume":"14","author":"Robertson","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.10.016_bib38","doi-asserted-by":"crossref","first-page":"124","DOI":"10.12688\/wellcomeopenres.15329.1","article-title":"C57BL\/6 and 129 inbred mouse strains differ in Gbp2 and Gbp2b expression in response to inflammatory stimuli in\u00a0vivo","volume":"4","author":"Clough","year":"2019","journal-title":"Wellcome Open Res."},{"key":"10.1016\/j.ymthe.2024.10.016_bib39","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41577-022-00813-1","article-title":"Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infection","volume":"23","author":"Zhang","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2024.10.016_bib40","article-title":"The Effects of Secretory IgA in the Mucosal Immune System","volume":"2020","author":"Li","year":"2020","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ymthe.2024.10.016_bib41","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1080\/21645515.2021.1976580","article-title":"Building a better antibody through the Fc: advances and challenges in harnessing antibody Fc effector functions for antiviral protection","volume":"17","author":"Gunn","year":"2021","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.ymthe.2024.10.016_bib42","doi-asserted-by":"crossref","first-page":"eabj6824","DOI":"10.1126\/scitranslmed.abj6824","article-title":"Escape from recognition of SARS-CoV-2 variant spike epitopes but overall preservation of T\u00a0cell immunity","volume":"14","author":"Riou","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2024.10.016_bib43","article-title":"Lipid nanoparticle composition for adjuvant formulation modulates disease after influenza virus infection in QIV vaccinated mice","author":"Jangra","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.ymthe.2024.10.016_bib44","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.add4853","article-title":"Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccination","volume":"7","author":"Tang","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.ymthe.2024.10.016_bib45","doi-asserted-by":"crossref","first-page":"6871","DOI":"10.1038\/s41467-021-27063-4","article-title":"Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization","volume":"12","author":"Lapuente","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.10.016_bib46","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1038\/s41590-024-01951-5","article-title":"Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primates","volume":"25","author":"Gagne","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2024.10.016_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104298","article-title":"Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose phase I trial","volume":"85","author":"Madhavan","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ymthe.2024.10.016_bib48","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1021\/mp4005029","article-title":"Formulation and characterization of nanoemulsion intranasal adjuvants: effects of surfactant composition on mucoadhesion and immunogenicity","volume":"11","author":"Wong","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ymthe.2024.10.016_bib49","article-title":"Formulation, high throughput in\u00a0vitro screening and in\u00a0vivo functional characterization of nanoemulsion-based intranasal vaccine adjuvants","volume":"10","author":"Wong","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2024.10.016_bib50","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1021\/acsomega.0c03512","article-title":"Characterization of the SARS-CoV-2\u00a0S Protein: Biophysical, Biochemical, Structural, and Antigenic Analysis","volume":"6","author":"Herrera","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.ymthe.2024.10.016_bib51","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/s41467-020-15562-9","article-title":"Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV","volume":"11","author":"Ou","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.10.016_bib52","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-03154-6","article-title":"Calibration of two validated SARS-CoV-2 pseudovirus neutralization assays for COVID-19 vaccine evaluation","volume":"11","author":"Huang","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2024.10.016_bib53","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1080\/22221751.2020.1838955","article-title":"Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection","volume":"9","author":"Rathnasinghe","year":"2020","journal-title":"Emerg. Microbes Infect."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624006762?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624006762?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:07:11Z","timestamp":1778616431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001624006762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":53,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1525001624006762"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.10.016","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced mucosal SARS-CoV-2 immunity after heterologous intramuscular mRNA prime\/intranasal protein boost vaccination with a combination adjuvant","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}